Iptakalim hydrochloride - ≥98% , CAS No.642407-63-4

CAS: 642407-63-4 Cat. No.: I651471 Molecular Weight: 179.73 EC Number: 863-964-9 PubChem CID: 11446679

GRADE & PURITY ≥98%

Storage

Store at 2-8°C,Desiccated

Shipped In

Wet ice

Overview

Iptakalim hydrochloride, a lipophilic para-amino compound, is a novel ATP-sensitive potassium channel (K ATP ) opener, as well as an α 4 β 2 -containing nicotinic acetylcholine receptor (nAChR) antagonist.

In Vitro

Iptakalim (Ipt) hydrochloride has been shown to reverse pulmonary resistance vascular remodeling, inhibit proliferation of pulmonary arterial smooth muscle cells (PASMCs) and airway smooth muscle cells (ASMCs), as well as protect PAECs from pathological stimulation. Iptakalim has an inhibitory effect on [Ca 2+ ]cyt increase and the proliferation of pulmonary arterial SMCs induced by endothelin-1 through activation of K ATP channels. Iptakalim (10 μM, 10 min) pretreatment of pulmonary arterial SMCs significantly prevents ransient ncrease of [Ca 2+ ]cyt elicited by endothelin-1. Iptakalim at he concentrations of 0.1, 1, and 10 AM lowered[3H]thymidine incorporation by 19.75±4.60% (n=10), 41.20±9.49% (n=10), and 54.74±10.11% (n=10), respectively, compared with that of cells treated only with endothelin-1. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Iptakalim (10-60 mg/kg) attenuates nicotine-evoked conditioned responding. Iptakalim also attenuates chamber activity in these nicotine test sessions. .\nIptakalim (60 mg/kg) pretreatment significantly reduced activity (LSD comparisons). . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Thirty male Sprague-Dawley rats weighing 275-299 grams. Dosage: 0, 10, 30, or 60 mg/kg. Administration: IP, 10 min before the start of a 4-min test session. Result: Decreased chamber activity. Dipper entries following pretreatment with 30 and 60 mg/kg Iptakalim were significantly lower than with 0 (saline) or 10 mg/kg iptakalim pretreatment (Tukey HSD tests).

Form:Solid

Specifications

Specifications & Purity

≥98%

Biochemical and Physiological Mechanisms

Iptakalim hydrochloride, a lipophilic para-amino compound, is a novel ATP-sensitive potassium channel (K ATP ) opener, as well as an α 4 β 2 -containing nicotinic acetylcholine receptor (nAChR) antagonist.

Storage

Store at 2-8°C, Desiccated

Shipped In

Wet ice

This product requires cold chain shipping. Ground and other economy services are not available.

Action Type

ACTIVATOR

Purity

≥98%

Names and Identifiers

• Isomeric SMILES: CC(C)C(C)(C)NC(C)C.Cl
• PubChem CID: 11446679
• Molecular Weight: 179.73

Chemical and Physical Properties

• Solubility: H2O : 25 mg/mL (139.10 mM; ultrasonic and warming and heat to 70°C)
• Molecular Weight: 179.730 g/mol
• Hydrogen Bond Donor Count: 2
• Hydrogen Bond Acceptor Count: 1
• Rotatable Bond Count: 3
• Exact Mass: 179.144 Da
• Monoisotopic Mass: 179.144 Da
• Topological Polar Surface Area: 12.000 Ų
• Heavy Atom Count: 11
• Formal Charge: 0
• Complexity: 92.900
• Isotope Atom Count: 0
• Defined Atom Stereocenter Count: 0
• Undefined Atom Stereocenter Count: 0
• Defined Bond Stereocenter Count: 0
• Undefined Bond Stereocenter Count: 0
• The total count of all stereochemical bonds: 0
• Covalently-Bonded Unit Count: 2

XLogP3